62 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
employees, including our named executive officers, including health, dental, life, vision and disability insurance.
We do not maintain any defined
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
11 Mar 24
Other Events
4:09pm
with a higher score indicating a greater level of disability. FXN Level* (% of Normal Level) Age of Onset (Years) FARS** (Change/Year) 11.2 7 2.9 22.0 11 … score indicating a greater level of disability. **FXN levels measured in peripheral blood mononuclear cells (PBMCs). FXN levels as measured
8-K
EX-99.3
LRMR
Larimar Therapeutics Inc
11 Mar 24
Other Events
4:09pm
with a higher score indicating a greater level of disability. FXN Level* (% of Normal Level) Age of Onset (Years) FARS** (Change/Year) 11.2 7 2.9 22.0 11 2.1
8-K
EX-1.1
m6ffj5lckj5
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
424B5
u3qcfsini r3b
14 Feb 24
Prospectus supplement for primary offering
5:08pm
424B5
q6qr4hh86 a2
13 Feb 24
Prospectus supplement for primary offering
4:46pm
8-K
EX-99.3
lx28b4tjgasf350
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.2
uf7 3zrdj
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.2
snceakny
14 Nov 23
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
12:00am
8-K
EX-99.1
jg7x1d idv2
14 Aug 23
Other Events
8:00am
8-K
EX-1.1
leossodgcv5 7y21
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-10.1
gk72xkuvkxc0 g6cp
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm
8-K/A
EX-10.1
sa9kgay7md0t 4fy9zl5
29 Sep 20
Departure of Directors or Certain Officers
4:39pm